|
Volumn 23, Issue 8, 2004, Pages 943-946
|
Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPOCH PROTOCOL;
ETOPOSIDE;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
NEUTROPENIA;
PERIPHERAL T CELL LYMPHOMA;
REMISSION;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
LYMPHOMA, T-CELL, PERIPHERAL;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEUTROPENIA;
PREDNISONE;
REMISSION INDUCTION;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 16644395432
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|